Does made for me mean approved?
A medicine mixed to order is called compounded. A personal prescription and an FDA-reviewed medicine are different things. Ask which kind is on offer.
In the U.S., medicine review is handled by the Food and Drug Administration (FDA).
A medicine mixed for me has the same approval as a factory medicine.
The assumption falls shortMade to order does not mean approved.
As of September 2026, compounded medicines lack FDA approval; before sale, the FDA does not review their safety, results or quality.
What does compounded mean?
As of September 2026, a regular pharmacy may lawfully prepare medicine on prescription for an identified patient, provided it meets federal requirements for the ingredients and preparation.
It can fill a need that a ready-made product cannot, such as leaving out a dye that causes an allergy.
That gives you a useful question: What need of mine calls for a changed medicine? Ask for the reason in plain words.
Also ask for the exact ingredient and the pharmacy’s name. A label saying custom does not answer either question.
Can a pharmacy make any peptide?
As of September 2026, federal rules limit which raw ingredients can be used in ordinary pharmacy compounding.
If the U.S. Pharmacopeia or National Formulary has a written quality standard for that ingredient, the pharmacy must meet it.
Without that written standard, the raw ingredient must be used in an FDA-approved medicine; if it meets neither condition, the FDA’s allowed-ingredient list must include it.
Ask the person prescribing it: Which of these rules allows this exact ingredient, and can you show me the record? Ask the pharmacy to explain the quality standard in everyday words. The word peptide does not answer those questions.
Does a shortage still allow copies?
Semaglutide and tirzepatide are medicines used for diabetes or weight control, depending on the product.
They appear here because offers for pharmacy-made copies raise a question about shortages, rather than proving a benefit for living longer.
As of September 2026, the FDA’s national shortage list includes neither semaglutide injections nor tirzepatide injections.
As of September 2026, ordinary pharmacies face limits on regularly making copies of medicines already available commercially.
The person prescribing can decide that changing a medicine makes an important difference for a particular patient’s care; making it cheaper alone is not enough.
Ask: What would you change in this medicine, and why does that change matter for me? Leaving out an allergy-causing dye is one example to discuss. A cheaper version alone does not explain a personal medical need.